GlassScriptPhysician profile
Ian H Newmark
NPI 1376563502
$11,137.91
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,981 · 2020: $1,378 · 2021: $2,190 · 2022: $2,497 · 2023: $1,694 · 2024: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,090.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,208.05 | 2019-2024 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $1,919.17 | 2019-2024 | Airsupra, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $1,566.18 | 2019-2024 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $1,010.65 | 2019-2024 | |
| Electromed, INC. | $647.65 | 2019-2024 | Smartvest |
| Grifols USA, LLC | $590.47 | 2019-2024 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $587.85 | 2019-2024 | Dupixent |
| Amgen INC. | $482.68 | 2021-2024 | Tezspire |
| Baxter Healthcare | $372.13 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Mylan Specialty L.P. | $232.57 | 2021-2024 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $196.25 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $194.54 | 2023-2024 | Aralast, Glassia |
| Advanced Respiratory, INC | $182.51 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $108.18 | 2019-2021 | |
| Covis Pharma Gmbh | $102.96 | 2022-2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $99.67 | 2022 | |
| Mallinckrodt Hospital Products INC. | $96.21 | 2022-2023 | Acthar |
| Horizon Therapeutics Plc | $86.71 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $79.53 | 2019-2020 | |
| Circassia INC. | $79.32 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $57.70 | 2024 | Opsumit |
| Inogen, INC. | $45.67 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Genentech USA, INC. | $40.18 | 2019 | |
| Philips North America LLC | $31.64 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $22.55 | 2021 | |
| Inspire Medical Systems, INC. | $21.80 | 2024 | Inspire |
| Resmed Corp | $21.18 | 2019 | |
| Gilead Sciences, INC. | $19.87 | 2021 | |
| Phadia US INC. | $19.54 | 2023 | Immunocap |
| Sanofi-Aventis U.S. LLC | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Newmark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.